Association between delay and increased mortality significant for 13 of 17 indications.
Results of a large cohort study investigated sources of iatrogenic and noniatrogenic injuries in women coping with a potential diagnosis of cervical cancer.
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30.
Nondetection rate is 13.1 percent for cotesting, higher when testing is done >12 months prediagnosis.
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26.